AMRX | Amneal Pharmaceuticals, Inc. Class ANASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$20.21
-$0.23 (-1.13%)

Amneal Pharmaceuticals, Inc. Class A (AMRX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.

The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
above both $20.21 vs 50 $19.22 / 200 $15.81
Projection
No cross projected
Test
No active test
Last cross
Golden cross 13 Aug 2025 ยท projected 17 bars out

Weekly as of 30 Oct 16:00 ET

Price
above both $21.51 vs 50 $15.19 / 200 $8.43
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 25 Mar 2024 ยท projected 25 bars out

4-hour as of 3 Nov 13:30 ET

Price
between the two $20.19 vs 50 $20.19 / 200 $18.35
Projection
No cross projected
Test
No active test
Last cross
Golden cross 16 Jun 2026 ยท projected 27 bars out

Cross history

19
crosses on record since 2020
11 golden8 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
16 Jun 2026Golden4-hour27 bars outNot tested
30 Mar 2026Death4-hour30 bars out2 bar cross test
13 Aug 2025Golden moderatedaily17 bars outNot tested
8 Jul 2025Golden4-hour29 bars outโ€”
21 Apr 2025Death moderatedaily25 bars outNot tested

About AMRX

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$48.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandmid

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.